Torrent Pharma - DF, Lower Interest/Tax Drive Earnings
TRP continues to strengthen its presence in DF market through the addition of MRs and enhancing its reach in the consumer health segment.
206 Views
Torrent Pharma: Steady Growth and Margin Visibility Outlook Intact. Maintain ADD
The recent ~9% stock price correction for Torrent Pharma (TRP) was due to a ~3% stake sale by the promoter group (Mehta Family)
393 Views
Torrent Pharma: Focus on branded generics and profitability. Maintain ADD
In its FY24 annual report, Torrent Pharma (TRP) has highlighted strategic themes that align with its short, medium and long-term goals
315 Views
HSIE Results Daily: DLF, Torrent Pharma, Dixon Technologies, Zydus Lifesciences...
DLF reported a stable quarter with pre-sales of INR 20.3bn (+39.1%/-83.2% YoY/QoQ), largely on the back of sustenance sales from recently-launched...
179 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an “Executive Order” (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
133 Views